Healthcare -
Biotechnology - NASDAQ - US
$ 1.65
-1.2 %
$ 51.2 M
Market Cap
-0.84
P/E
Price Target
Average
718.18%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
5.75%
Net Income
Estimate
26.08%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immuneering Corporation
Wall Street analysts predict an average 1-year price target for IMRX of $13.5 , with forecasts ranging from
a
low of
$3 to a high of $41 .
IMRX Lowest Price Target
Wall Street Target
3 USD
81.82%
IMRX Average Price Target
Wall Street Target
13.5 USD
718.18%
IMRX Highest Price Target
Wall Street Target
41 USD
2384.85%
REVENUE FORECAST
Revenue Forecast Chart IMRX
EBIT FORECAST
EBIT Forecast Chart IMRX
NET INCOME FORECAST
Net Income Chart IMRX